Cell and Gene Therapy

About Conference

We welcome all the attendees to the 7th Global Conference on Cell and Gene Therapy which will be held on July 15-16, 2024 in  London, UK . WORLD CELL THERAPY 2024 based on the theme “Advancements and Breakthroughs in Cell and Gene Therapy”. CELL THERAPY provides an exceptional opportunity for the participants or delegates with their relative backgrounds to share their research ideas and to learn from other colleagues and co-partners about the modern scientific improvements and innovation.

This conference plays a Global platform for biomedical companies, start-ups, clinical research divisions, professionals, specialists, consultants, doctors, scholars and students to frame new relationship and strengthen the Knowledge. This is a great opportunity for all the delegates from Universities and Institutes to interact with the top grade world class Scientists. The particular participants can confirm their participation through Registrations. To explore More Regarding the Recent Research in Cell and Gene therapy attends in World cell therapy 2024

Why to attend?

Cell Therapy is one of the world's leading conferences in the present scenario to bring together all the participants to exchange and bring discoveries of Immunotherapy, Cancer Therapy, Nanotechnology in cell, Cellular Therapies, Cell Culture and Bioprocessing, etc.

Who can attend?

World Cell Therapy 2024 brings together individuals who have an interest in different fields of Genetic Engineering like Immunologists, Biotechnologists, Health-care professionals, Cell and Cancer therapy Faculties & associations.

Target Audience:

Researchers and Students

Biotechnologists

Immunologists

Pharmaceutical Experts

Genetics Associations and Societies

Molecular biologists

Young Researchers

Bio-pharmacists

Young Researchers Forum - Young Scientist Awards Gene Therapy 2024

Young Research’s Awards at Gene Therapy 2023 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at the World Cell Therapy 2023 young research forum.

Young Scientist Benefits

• Our conferences provide best Platform for your research through oral presentations.
• Share the ideas with both eminent researchers and mentors.
• Young Scientist Award reorganization certificate and memento to the winners
• Young Scientists will get appropriate and timely information by this Forum.
• Platform for collaboration among young researchers for better development

Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Session and Tracks

Session 1: Cell Science and Stem Cell Research
Stem Cell Research & Therapy is the major domain for translating analysis into stem cell therapies. It is a peer-reviewed international conference that publishes high-quality open research access journals with a focus on basic, translational, and clinical research into stem cell treatments and regenerative medicines, including animal models and clinical trials.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 2: Stem Cell Therapies

Stem cells are constant cells found in cell living organisms that get separated through a cell division and then gets separate into a particular cell. The two properties of foundational microorganisms which are used to separate them in very body cell are self-restoration and proficiency. Because of their prospective job in different conducts, a foundational microorganism is subjected as inside and outside examination of Extensive Research Science.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 3: Cell Culture and Bio processing

Stem cells are the basic materials of body cells from that all different cells will be specialized and functions are generated. Below the proper condition with in the body or a laboratory, stem cells divide to create a lot of cells called daughter cells.

These daughter cells will either become new stem cells (self-renewal) or else become specialized cells with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No different cell with in the body has the natural ability to generate new type of cell.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 4: Viral gene therapy   
The viral life cycle can be separated into two temporally distinct phases: infection and replication. This is known as the viral vectorization process. A sufficient quantity of a therapeutic gene must be delivered into the target tissue without significant harm for gene therapy to be effective. Each viral vector system has a unique set of characteristics that influence the applications for which it is suitable for use in gene therapy. For some diseases—for instance, hereditary disorders—long-term expression from a tiny percentage of cells would be sufficient, whereas other illnesses would call for high-but-transient gene expression. Gene transfer may be necessary into a significant portion of the aberrant cells, for instance, in gene therapies intended to disrupt a viral infectious process or restrict the proliferation of cancer cells by reactivating inactivated tumour suppressor genes.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 5: Stem Cell in Drug Development

Undefined cell treatment has been opened another way in the territory of medication disclosure and improvement. Biopharmaceutical organizations have been working in interpreting fundamental utilizations of undefined cell advances in the medication improvement forms in order to diminish the high weakening rate generally arrange sedate applicants, which has been developing at a quick place in the previous decade.

Approach of unformed microorganism advances has given new expectation to fabricate imaginative cell models. The always developing systems utilized for detachment of human/creature embryonic foundational microorganisms (ESCs), bone marrow-determined mesenchyme developed cells, umbilical line undifferentiated organisms, grown-up tissue-particular neural immature microorganisms and human instigated pluripotent foundational microorganisms (iPSC) have prompted the headway of varied high throughput and combinatorial screening advancements consequently supplementing the a  part of undifferentiated organism models in sedate disclosure

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 6: Nanotechnology in Stem Cell
In recent years, stem cell nanotechnology has emerged as a replacement of exciting field. Experimental and Theoretical studies of interaction between nanostructures or nanomaterial’s and stem cells have created nice advances. The importance of nanotechnology, nanostructures, and nanomaterial’s to the elemental developments in stem cells-based therapies for injuries and degenerative diseases has been recognized. In general, the consequences of properties and structure of nanomaterials on the accretion and differentiation of stem cells became a replacement of integrative border in reconstruction medicine and material science

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 7: Stem Cell in Cardiovascular Disease
Cardiovascular Diseases (CVD) includes congestive heart failure stroke and hypertension, coronary artery disease. Most of these diseases may occur when there is a less oxygen supply to heart cells / Cardiomyocytes which damaged as being supplied by less oxygen as well as less blood which we can treated by stem cell therapy by inducing some bone-marrow derived mononuclear cells, umbilical cord blood cells, Mesenchyme stem cells or Cardiac stem cells in to the damaged portion of heart. These cells interspersed in to heart and secrete certain portions and paracrine factors that repair of the damaged area by cardiac tissue Regeneration.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

 

Session 8: Novel Stem Cell Therapy             
The number of individuals with chronicle wounds has been increasing worldwide due to a fading population, diabetes, obesity, and cardiovascular disease. In the U.S, almost seven million people have chronic skin ulcers. Many restorative approaches have been used. Whatever, the treatment comes out  are not always ideal because of failure to achieve complete wound closure in around 60% of cases, scarring, and high rate of recurrence. However, there is a need of more effective therapies. Stem cells offer promising possibilities. Pre-clinical studies have shown that bone- or adipose tissue-derived mesenchyme stem cells (MSCs) have a competitive advantage over other types of stem cells due to their better defined multi potent differentiating potential, paracrine effects, immune modulatory properties, and safety.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 9: Stem cell engineering     

The modification and tuning of stem cells is a separate area of cell engineering. The aforementioned cell engineering techniques encompass a large portion of current research on stem cell therapies and treatments. Because they can differentiate into a variety of other cell types, stem cells are exceptional in that they can be modified to provide novel therapies or serve as a starting point for more cell engineering projects. One example of directed stem cell engineering is the generation of pro-myogenic factors for the treatment of sarcopenia or muscle atrophy by partially developing stem cells into myocytes.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

 

Session 10: Cellular Therapies
Cell therapy (also called cellular transplantation, cell therapy, or cytotherapy) is a therapy in which possible cells are injected, implant or embed into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 11: Advanced Gene Therapeutics

he capability to make specific modifications to the human gene has been an objective in medical since; gene is the recognition of the basic unit for heredity. Therefore, gene therapy is defined as the capability of genetic improvement through the correction of modified genes or specific modifications that target therapeutic treatment. This therapy became possible through the advances of genetics and bioengineering that enabled manipulating vectors for delivery of extra chromosomal material to target cells. One of the major focuses on this technique is the optimization of delivery vehicles (vectors) that are mostly plasmas, unstructured or viruses. These viruses are more often investigated due to their excellence of infected cells and inserting their genetic material.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 12: Immunotherapy          

Immunotherapy is considered as a type of cancer treatment that helps your immune system to fight against cancer. The immune system helps your body to fight with infections and other diseases. It is consists of organs and white blood cells and tissues of the lymph system. Immunotherapy is a type of biological therapy. Organic therapy is a type of treatment that we use from the substances made from living organisms to treat cancer.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 13: Cancer Therapies

There are many types of cancer treatment. Which types of treatment that you can prescribe will depend on the type of cancer that you have and how advanced it is. Some people who were facing with cancer will have only one treatment. But most people have a rear case in combination of treatments, such as surgery with chemotherapy and also with radiation therapy. When you need a treatment for cancer, you have a lot to think and learn about. It is normal to feel affected and confused. But, talking with your doctor and learning about which type of treatment you may have can help you feel better and can control the fear.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 14: Nano-Therapy

At the present scenario Cancer therapies are not basing on surgery, radiation, and chemotherapy. Because of all these three methods cause a risk damage to normal tissues or incomplete destruction of the cancer. Nano- therapy means to target chemotherapies and also collectively to cancerous cells and neoplasms, guide in surgical resection of tumour and enhance the therapeutic competence of radiation-based and the other current based treatment methods. All these together can decrease the risk to the patient and an increased probability of survival.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 15: Human Gene Therapy

Human gene therapy and its function for the treating the human genetic disorders, such as cystic fibrosis, cancer, and other diseases, are considered. Gene therapy is defined as a technique in which a functioning gene is stuck in into a human cell to correct a genetic error or else to introduce a new functioning to the cell. Many methods, including viral vectors and non-viral vectors, have been developed for both ex vivo and in vivo gene transfer into cells. There are several safety and ethical issues related to manipulating the human gene that need to be resolved. Current gene therapy efforts focus on gene insertion into stem cells only. The current human gene project provides the sequences of a vast number of human genes, leading to the identification, characterization, and understanding of genes that are responsible for many human diseases

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

 

Session 16: Diabetes Gene Therapy

New approaches to the treatment and cure of type 1 diabetes may be developed as a result of recent advances in molecular and cell biology. In instance, the restoration of insulin secretion through gene or cell-replacement treatment can currently be predicted. Over 180 million individuals worldwide are affected with diabetes mellitus, which is on the rise. The majority of cases of diabetes are type 2, and by 2030, the incidence is anticipated to have more than quadrupled due to the ageing population expansion and sharp rise in obesity prevalence.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

 

Session 17: Molecular Epigenetics

Epigenetics is rising to eminence in biology as a mechanism by which environmental factors have intermediate-term effects on gene expression without changing the underlying genetic sequence. It can occur through the specific methylation of DNA bases and modification of histones. There are wide-feeding implications for the gene-environment contest and epigenetic mechanisms are causing a revaluation of many traditional concepts such as heritability. The reversible nature of epigenetics also provides conceivable treatment or prevention prospects for diseases previously thought hard-coded into the gene. Therefore, we consider how growing knowledge of epigenetics is altering our understanding of biology and medicine, and its implications for future research.

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 18: Genetic Vaccines

Vaccination consists of appealing the immune system with a contagious agent, or components of a contagious agent, modified in such a manner that there is no harm or disease, but securing that when the host is resisted with that contagious agent, the immune system can appropriately neutralize it before it causes any illness. A hundred years vaccination has been bring out  by one of two match either introducing specific antigens against which the immune system reacts directly or introducing live attenuated infectious agents that replicate within the host without causing disease synthesize the antigens that subsequently prime the immune system.

 

 

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

 

 

Session 19: Bioengineering Therapeutics

Therapeutics Engineering assembles understanding of bodily responses to imputable materials and drug delivery devices. These focus on the biomaterial selection and fusion and also in depth study of drug design, manufacturing, and delivery. We will be getting trained in Nano-materials, material properties, transport phenomena, biochemical engineering, and metabolic engineering. Application areas include analyse therapeutics, biomimetic, and drug delivery systems.

Advancing technologies to detect and differentiate disease states and treatment responses (i.e., biomarkers) rapidly and precisely

 

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

 

Session 20: Clinical Trials and Research in Cell and Gene Therapies

Almost every cell and gene therapy the clinical trial is dissimilar in some way. Working with living organisms presents new and dissimilar challenges to the traditional clinical trial model. With over 400 decades CGT professionals globally, ICON has developed tools and best practices to transform CGT trial design and implementation. From site selection to study start up through implementation, ICON supply project management, clinical services, product-specific logistics solutions, data flow, regulatory strategy and central laboratory services. 

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 21: Skin Cell Therapy

Stem cells have gained a lot of popularity in the cosmetics industry. Skincare professionals do not use embryonic stem cells since live materials cannot be incorporated into skincare products. Instead, scientists are developing solutions containing specialized peptides, enzymes, or plant stem cells that, when applied topically to the skin's surface, aid in either stimulating or protecting the skin's own stem cells from harm and degeneration. 

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 22: HIV Gene Therapy

In patients with HIV, highly active antiretroviral therapy significantly increases survival. The existence of drug-resistant escape mutations, cumulative toxicities, and partial immunological recovery can make lifelong treatment more difficult as a result of the persistence of HIV in reservoirs. In the absence of long-term antiviral medication, cell and gene therapies hold the potential of avoiding progressive HIV infection by blocking HIV replication. 

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

Session 23: Cell Therapy in Pulmonology

Depending on the level of inflation, the human lung's surface area ranges from 35 to 100 m2, enabling an efficient exchange of the oxygen required for oxidative metabolism. Toxins in the air as well as microorganisms and their by-products are exposed to this contact area. Despite these on-going assaults, the lung in healthy people is able to govern tissue plasticity required for injury repair as well as immunological reactions (upregulation and down-modulation of responses), allowing the maintenance of homeostasis. 

Cell and Gene therapy conference | Cell and Gene therapy meetings | Stem Cell conference | Gene therapy events | Biochemistry meetings | Cellular biology events

 

Benefits of Participation

Benefits of Participation for Speaker

• Worldwide appreciation of the profile of Researchers.
• Obtain credits for professional growth.
• Explore the latest of cutting edge analysis.
• Make long-term bonds at social and networking activities.
• An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
• Learn a transition beyond your area of interest to learn more about new subjects and studies away from your core subject of Genetics.
• We have distinctive networking, learning and enjoyable integration into a single package.

Benefits of Participation for Delegate

• Professional Development-Improve understanding and knowledge.
• Attendance at Conference supports rejuvenates and energises delegates.
• Your involvement in our Conference will help with a new methodology and ideology that can be used to broaden the outcomes of businesses or industries.
• Opportunities for Global Summit researchers and experts in the same field to meet and exchange new ideas through Conference.

Benefit of Participation for Sponsor

• Exposure to the international environment would increase the possibility of new companies.
• Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of international participants.
• Increase business by our Conference participants through lead generation.
• It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and objective.
• Conferences in Cell and gene therapy provide opportunities for more attention and contemplation that could help you move your company to the next stage.
• Benchmarking main organization plans and moving it forward.
• Get feedback from trustworthy people at our webinar to your company questions and challenges.
• On our Conference banner, website and other proceedings, branding and marketing content, the advertising logo of your company.

Benefit of Association for Collaborators

• Nobody has these massive visitors to Cell and Gene Therapy Conference in the world; this is the best forum to highlight society.
• Creating long-lasting peer relationships.
• In our Conference banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.

Market Analysis

The worldwide Cell and Gene Therapy quality treatment showcase come to a esteem of about $4,390.3 million in 2020, having expanded at a compound yearly development rate (CAGR) of 25.5% since 2015.

This report portrays and clarifies the worldwide cell and quality treatment advertise and covers 2015 to 2020, named the noteworthy period, and 2020 to 2025 named the figure period, at the side advance estimates for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.

The market is anticipated to develop from $4,390.3 million in 2020 to $15,482.3 million in 2025 at a rate of 28.7%. The showcase is at that point anticipated to develop at a CAGR of 17.3% from 2025 and reach $34,317.9 million in 2030.

Increased investments in cell and gene therapies, growth in research and development, advances in cancer drug discovery, rise in public-private partnerships, strong economic growth in emerging markets, increased healthcare expenditure, and rising pharmaceutical R&D expenditure all contributed to the market's growth in the historic period. The market was restrained by inadequate reimbursements, challenges due to regulatory changes, low healthcare access, and limited number of treatment centres. in 2030.